Latest News

Obicetrapib Lowers LDL-C in Familial Hypercholesterolemia
Written by: Radcliffe CVRM
Obicetrapib Lowers LDL-C in Familial Hypercholesterolemia
Ticagrelor Fails Noninferiority to Prasugrel in TUXEDO-2
Written by: Radcliffe CVRM
Ticagrelor Fails Noninferiority to Prasugrel in TUXEDO-2
Enlicitide: Oral PCSK9 Inhibitor Lowers LDL-C by 56%
Written by: Radcliffe Cardiology
Enlicitide: Oral PCSK9 Inhibitor Lowers LDL-C by 56%
Study: 6 in 10 US Adults Eligible for CKM Drugs
Written by: Radcliffe CVRM
Study: 6 in 10 US Adults Eligible for CKM Drugs
BI 764198 Reduces Proteinuria in FSGS Phase 2 Trial
Written by: Radcliffe CVRM
BI 764198 Reduces Proteinuria in FSGS Phase 2 Trial
Metabolite Profile Predicts Future Type 2 Diabetes Risk
Written by: Radcliffe CVRM
Metabolite Profile Predicts Future Type 2 Diabetes Risk
Tirzepatide Cuts Cardiometabolic Risk in OSA, Obesity
Written by: Radcliffe CVRM
Tirzepatide Cuts Cardiometabolic Risk in OSA, Obesity
New Horizons in Dyslipidaemia 2026
Written by: Radcliffe CVRM
New Horizons in Dyslipidaemia 2026
Global Economic Burden of Diabetes to Exceed $10 Trillion
Written by: Radcliffe CVRM
Global Economic Burden of Diabetes to Exceed $10 Trillion
Metabolome-Informed BMI Better Predicts CVRM Risk
Written by: Radcliffe CVRM
Metabolome-Informed BMI Better Predicts CVRM Risk

External news

Written by: Medscape
Paradigm Change Coming in Secondary Stroke Prevention
Written by: Medscape
AI Mammography Flags Cardiovascular Risk
Written by: Medscape
Direct Oral Anticoagulants Linked to Fewer Brain Bleeds
Written by: heart.org - Heart news
Loneliness linked to increased risk of degenerative heart valve disease
Written by: Cardiovascular Business
Outgoing SCAI president reflects on a busy year full of partnerships and advocacy
Written by: Cardiovascular Business
FDA clears next-gen device for left-heart access
Written by: Medscape
Countertransference: A Practical Picture for All Physicians
Written by: Medscape
Prescribing Orforglipron for Obesity
Written by: Cardiovascular Business
Heartflow sues cardiology AI rival Cleerly over alleged patent infringement
Written by: Medscape
Top 10 Takeaways From a PALS Recertification